File image: A health official draws a dose of a COVID-19 vaccine
More than 47.85 crore vaccinations have been administered across India, according to the August 3 update, with 61,09,587 new vaccination doses administered on Monday.
It said that on Monday 27,76,234 jabs were administered as the first dose and 4,82,253 as the second in the age group 18-44 years, according to the 7 pm provisional data. Cumulatively, 15,99,07,360 people in the age group 18-44 years across all states and union territories have received their first doses and total 93,86,280 their second since the start of phase-3 of the vaccination drive on May 1.
Of the total vaccinations administered to date, 78 percent are recipients of their first dose while 22 percent have received the second dose. Among states, Uttar Pradesh administered the most (cumulative) vaccine doses at 4.88 crore, followed by Maharashtra at 4.50 crore and Gujarat at 3.41 crore.
Follow our LIVE blog on the COVID-19 pandemic here
Here are key developments related to the COVID-19 vaccination process:
- More than 2.75 crore balance and unutilised COVID-19 vaccine doses are still available with the states, UTs and private hospitals to be administered, the Union Health Ministry said on Tuesday. Over 49.85 crore vaccine doses have been provided to states and UTs so far through all sources and a further 20,94,890 doses are in the pipeline. Of this, the total consumption including wastage is 47,52,49,554 doses, the ministry said.
- Johnson & Johnson (J&J) said it was engaged in discussions with the Indian government to launch its single-dose COVID-19 vaccine and the reports about the company withdrawing its proposal for speedy vaccine approval in India is untrue. J&J also said that there was no link between indemnity and the withdrawal of its application for bridging study. "We look forward to ongoing discussions with the Government of India and will continue to explore how to accelerate the availability of the Johnson & Johnson COVID-19 vaccine in India,” the J&J statement added.
- The Indian government is considering allowing people to “freely choose” mixed vaccine jabs for COVID-19 vaccines – as long as both options are of similar platforms. For example, individuals would be able to choose the first jab of Covishield and the second jab of Sputnik V — or vice versa, as both vaccines are adenovirus-based, or mix Pfizer and Moderna jabs, which are mRNA based. The move would address vaccine supply constraints and comes amid “growing evidence” that mixing vaccines is “not only safe but also produces a strong immune response”. This was suggested by the COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) and officials told the paper “final decision would be taken after considering scientific evidence”.
- Combining AstraZeneca's COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna's jab provides "good protection", Denmark's State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca's vaccine in April over rare side-effect concerns.
- COVID-19 vaccine hesitancy and coverage differ across religious groups, according to the YouGov-Mint-CPR Millennial Survey. Two-thirds (66.7 percent) of Hindus who were part of the survey had received at least one dose of a vaccine against COVID-19. But, among Muslims (47.9 percent) and Christians, only about a half took the vaccine. Religious minorities also reported being more worried about the safety and side effects of vaccines.Here are the vaccination counts for some states:
For full coverage on the coronavirus pandemic click here